INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 413m ago
HOUSE PTR13m ago
SEC 13F13m ago
ROBINHOOD CHAIN13m ago
Public company

Progyny, Inc.

PGNYCIK 0001551306

EDGAR filingsOpen in network
Price$34.84
1 year+84.5%
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score13
Connections with evidence5

PGNY · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
LS
Livingston Mark S.CHIEF FINANCIAL OFFICER
PGNYProgyny, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
2,139 sh
Nov 4, 2026Nov 6, 2026

Verified connections

  • ← Insider ofevidence
    ANEVSKI 2026 SOUTH DAKOTA NGCG TRDirector, Officer · Form 144 · Nov 4, 2026
  • ← Insider ofevidence
    DAVID SCHLANGERDirector, Officer · Form 144 · Nov 4, 2026
  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8090 · Services-Misc Health & Allied Services, NEC · Nov 4, 2026
  • ← Insider ofevidence
    Swartz AllisonEVP, GC · Nov 4, 2026
  • ← Insider ofevidence
traded Nov 4, 2026
+2d
SEC FORM 4

Evidence

13
SA
Swartz AllisonEVP, GC
PGNYProgyny, Inc.
Grant or award
A—
8,160 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
SA
Swartz AllisonEVP, GC
PGNYProgyny, Inc.
Grant or award
A—
11.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Livingston Mark S.
Officer · Form 144 · Nov 3, 2026

Planned sales and 5% stakes

Form 144, 13D and 13G
  • PAPETER ANEVSKIDirector, Officer · sale around Nov 5, 2026 · 314.7K shares · 10b5-1 plan$9.47MForm 144 · filed Nov 5, 2026
  • ATANEVSKI 2026 SOUTH DAKOTA NGCG TRDirector, Officer · sale around Nov 5, 2026 · 90.0K shares · 10b5-1 plan$2.71MForm 144 · filed Nov 5, 2026
  • DSDAVID SCHLANGERDirector, Officer · sale around Nov 5, 2026 · 200.0K shares · 10b5-1 plan$6.02MForm 144 · filed Nov 5, 2026
  • LSLivingston Mark S.Officer · sale around Nov 4, 2026 · 2,139 shares · 10b5-1 plan$64KForm 144 · filed Nov 4, 2026